Duchesnay Inc. has made Slynd (prescription drug) available to Canadian women in 2022. This contraception option came 50 years after the introduction of the initial progestin-only pill (POP) in 1972.
Exeltis USA announced the commercial launch of Slynd (drospirenone), which is indicated for use by females of reproductive potential to prevent pregnancy. Slynd is a progestin-only contraceptive that ...
Spanish pharma company Exeltis, which markets birth-control pill Slynd, was recently cited by American regulators for a paid Facebook post that omitted side-effect information. The Food and Drug ...
The Food and Drug Administration (FDA) has taken a firm stance against misleading advertising practices by issuing a warning to Exeltis, the manufacturer of the progesterone-only birth control pill, ...
On August 11, 2023, the Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) issued an untitled letter to Exeltis USA Inc. (Exeltis) regarding a promotional ...
FLORHAM PARK, N.J., Sept. 16, 2019 /PRNewswire/ -- Exeltis USA, Inc. a division of Insud Pharma (headquartered in Madrid, Spain) today announced the commercial launch of its oral contraceptive tablet ...
BLAINVILLE, Quebec, July 12, 2023 (GLOBE NEWSWIRE) -- Duchesnay Inc., a pharmaceutical company specializing in women's health and member of Duchesnay Pharmaceutical Group headquartered in Blainville, ...
BLAINVILLE, QC, Feb. 27, 2025 /PRNewswire/ - Duchesnay Inc., a pharmaceutical company specializing in women's health and member of Duchesnay Pharmaceutical Group, winner of the 2024 Life Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results